Home
/
Grants and Training
/
< Back To Funding Opportunities and Contacts
/
Clinical Trials Optimization

Clinical Trials Optimization

The NHLBI’s new funding announcements will help lead investigators to more interpretable, timely, and useful results, which in turn will improve public health. The NHLBI offers several funding mechanisms tailored to planning and conducting clinical trials at all phases, including pilot studies.

Program Officers

Traci Heath Mondoro, Ph.D.

Early Phase (0, I) Clinical Trials

NHLBI_Blood_Training@nhlbi.nih.gov

301-435-0050

Patricia Noel, Ph.D.

Early Phase Clinical Trials

noelp@nhlbi.nih.gov

301-435-0202

Nancy DiFronzo, Ph.D.

HSCT and Adoptive Cell Therapy; GVHD; MDS

nancy.difronzo@nih.gov

301-435-0065

Yves Rosenberg, M.D., M.P.H.

Multi/Single-Site Trials, DCVS

rosenbey@nhlbi.nih.gov

301-435-0550

Andrei Kindzelski, M.D., Ph.D.

Innovative Late Phase U34/X01 Trials

kindzelskial@nhlbi.nih.gov

301-435-0050

Kristin Burns, M.D.

Late Phase Trials, DCVS

kristin.burns@nih.gov

301-594-6859

Erin Smith

Innovative Clinical Trials Education and Consultative Resource

smithee@nhlbi.nih.gov

301-435-0065

Nahed El Kassar, M.D., Ph.D.

Phase II or Later Single Site Trials

nahed.elkassar@nih.gov

301-435-0065

Funding Opportunities

View all active NHLBI funding opportunities